Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Ixabepilone for Advanced Non-squamous NSCLC
NCT01057212Phase 2Terminated
- Start
- Feb 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC). Started Feb 2010; status: terminated.
02
Drugs
ixabepilone
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01057212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057212.